PRE 14A XBRL

PRELIMINARY PROXY STATEMENT

Company: MAINZ BIOMED N.V.
Filed: March 12, 2026
Period of Report: March 12, 2026
Accession Number: 0001213900-26-026681

View Document ↗ View on SEC.gov ↗